Risk of hypertension after CGRP antagonist treatment in migraine: A systematic review and meta-analysis.

Aimovig (erenumab-aooe) - Amgen

Emgality (galcanezumab-gnlm) - Eli Lilly, Daiichi Sankyo

http://www.ncbi.nlm.nih.gov/pubmed/42338082

ChaeSeong Lim; Dokyoung Kim; Kihun Kim; Kunhee Kim; Su-Yeon Cho; Tae-Jin Song; Won Ho Cho; Won Kyu Kim; Yujin Kwon; Yun Hak Kim

Jun 25, 2026